Seeking Alpha

BioCryst Pharmaceuticals (BCRX): Q4 EPS of -$0.29 beats by $0.04. Revenue of $5.2M (-68.9% Y/Y)...

BioCryst Pharmaceuticals (BCRX): Q4 EPS of -$0.29 beats by $0.04. Revenue of $5.2M (-68.9% Y/Y) misses by $2.2M. (PR)
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)